Sprint Bioscience AB (publ) (STO:SPRINT)
1.920
+0.060 (3.23%)
At close: Mar 4, 2026
Sprint Bioscience AB Employees
Sprint Bioscience AB had 30 employees as of December 31, 2025. The number of employees decreased by 8 or -21.05% compared to the previous year.
Employees
30
Change
-8
Growth
-21.05%
Revenue / Employee
5.57M SEK
Profits / Employee
3.06M SEK
Market Cap
202.59M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 30 | -8 | -21.05% |
| Sep 30, 2025 | 29 | -7 | -19.44% |
| Jun 30, 2025 | 36 | 0 | - |
| Mar 31, 2025 | 38 | 2 | 5.56% |
| Dec 31, 2024 | 38 | 10 | 35.71% |
| Sep 30, 2024 | 36 | 9 | 33.33% |
| Jun 30, 2024 | 36 | 9 | 33.33% |
| Mar 31, 2024 | 36 | 7 | 24.14% |
| Dec 31, 2023 | 28 | -4 | -12.50% |
| Sep 30, 2023 | 27 | -7 | -20.59% |
| Jun 30, 2023 | 27 | -8 | -22.86% |
| Mar 31, 2023 | 29 | -7 | -19.44% |
| Dec 31, 2022 | 32 | -3 | -8.57% |
| Sep 30, 2022 | 34 | -1 | -2.86% |
| Jun 30, 2022 | 35 | 0 | - |
| Mar 31, 2022 | 36 | 3 | 9.09% |
| Dec 31, 2021 | 35 | 7 | 25.00% |
| Sep 30, 2021 | 35 | 5 | 16.67% |
| Jun 30, 2021 | 35 | 2 | 6.06% |
| Mar 31, 2021 | 33 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Magle Chemoswed Holding AB | 144 |
| IRLAB Therapeutics AB | 31 |
| Bio-Works Technologies AB | 26 |
| NextCell Pharma AB | 24 |
| Mendus AB | 20 |
| Intervacc AB | 15 |
| Xintela AB | 13 |
| AlzeCure Pharma AB | 11 |